1. Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study. (19th December 2018) Authors: Kirschbrown, Whitney P.; Wynne, Chris; Kågedal, Matts; Wada, Russ; Li, Hanbin; Wang, Bei; Nijem, Ihsan; Badovinac Crnjevic, Tanja; Gasser, Helena; Heeson, Sarah; Eng‐Wong, Jennifer; Garg, Amit Journal: Journal of clinical pharmacology Issue: Volume 59:Number 5(2019) Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study. Issue 1 (January 2021) Authors: Tan, Antoinette R; Im, Seock-Ah; Mattar, André; Colomer, Ramon; Stroyakovskii, Daniil; Nowecki, Zbigniew; De Laurentiis, Michelino; Pierga, Jean-Yves; Jung, Kyung Hae; Schem, Christian; Hogea, Alexandra; Badovinac Crnjevic, Tanja; Heeson, Sarah; Shivhare, Mahesh; Kirschbrown, Whitney P; Restuccia... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer. (January 2023) Authors: Swain, Sandra M.; Tan, Antoinette R.; Gianni, Luca; Kuemmel, Sherko; Dang, Chau T.; Schneeweiss, Andreas; O'Shaughnessy, Joyce; Liu, Haiying; Aguila, Christian; Heeson, Sarah; Macharia, Harrison; Yang, Ke; Restuccia, Eleonora; Loibl, Sibylle Journal: European journal of cancer Issue: Volume 178(2023) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial. (May 2022) Authors: Gelber, Richard D.; Wang, Xin V.; Cole, Bernard F.; Cameron, David; Cardoso, Fatima; Tjan-Heijnen, Vivianne; Krop, Ian; Loi, Sherene; Salgado, Roberto; Kiermaier, Astrid; Frank, Elizabeth; Fumagalli, Debora; Caballero, Carmela; de Azambuja, Evandro; Procter, Marion; Clark, Emma; Restuccia, Eleono... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗